Business Description
![InnoCan Pharma Corp InnoCan Pharma Corp logo](https://static.gurufocus.com/logos/0C0000BPLB.png?14)
InnoCan Pharma Corp
NAICS : 325412
SIC : 3741
ISIN : CA45783P1027
Share Class Description:
INNPF: Ordinary SharesCompare
Compare
Traded in other countries / regions
INNO.CanadaIP4.GermanyINNPF.USA IPO Date
2020-11-24Description
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 691.11 | |||||
Equity-to-Asset | 0.46 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.43 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 35.4 | |||||
3-Year EPS without NRI Growth Rate | 15.1 | |||||
3-Year FCF Growth Rate | 10.2 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 0.45 | |||||
9-Day RSI | 4.7 | |||||
14-Day RSI | 11.36 | |||||
6-1 Month Momentum % | -33.5 | |||||
12-1 Month Momentum % | 2.94 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.06 | |||||
Quick Ratio | 1.46 | |||||
Cash Ratio | 1.06 | |||||
Days Inventory | 283.5 | |||||
Days Sales Outstanding | 0.33 | |||||
Days Payable | 45.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.5 | |||||
Shareholder Yield % | -4.1 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 88.06 | |||||
Operating Margin % | -19.89 | |||||
Net Margin % | -27.61 | |||||
FCF Margin % | -18.61 | |||||
ROE % | -113 | |||||
ROA % | -73.9 | |||||
ROIC % | -185.7 | |||||
ROC (Joel Greenblatt) % | -777.76 | |||||
ROCE % | -83.63 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.4 | |||||
PB Ratio | 11.5 | |||||
Price-to-Tangible-Book | 11.5 | |||||
EV-to-EBIT | -10.76 | |||||
EV-to-EBITDA | -10.85 | |||||
EV-to-Revenue | 2.3 | |||||
EV-to-FCF | -12.36 | |||||
Price-to-Net-Current-Asset-Value | 11.5 | |||||
Earnings Yield (Greenblatt) % | -9.29 | |||||
FCF Yield % | -7.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:INNPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InnoCan Pharma Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 18.865 | ||
EPS (TTM) ($) | -0.017 | ||
Beta | 0.2 | ||
Volatility % | 79 | ||
14-Day RSI | 11.36 | ||
14-Day ATR ($) | 0.001834 | ||
20-Day SMA ($) | 0.19775 | ||
12-1 Month Momentum % | 2.94 | ||
52-Week Range ($) | 0.145 - 0.3545 | ||
Shares Outstanding (Mil) | 280.66 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
InnoCan Pharma Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
InnoCan Pharma Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
InnoCan Pharma Corp Frequently Asked Questions
What is InnoCan Pharma Corp(INNPF)'s stock price today?
The current price of INNPF is $0.18. The 52 week high of INNPF is $0.35 and 52 week low is $0.14.
When is next earnings date of InnoCan Pharma Corp(INNPF)?
The next earnings date of InnoCan Pharma Corp(INNPF) is .
Does InnoCan Pharma Corp(INNPF) pay dividends? If so, how much?
InnoCan Pharma Corp(INNPF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |